The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Frequency and spectrum of ROS1 resistance mutations in ROS1-positive lung cancer patients progressing on crizotinib.
 
Justin F. Gainor
Honoraria - Merck
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech; Merck; Novartis
Research Funding - Adaptimmune; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Novartis
Travel, Accommodations, Expenses - Affymetrix
 
Luc Friboulet
No Relationships to Disclose
 
Satoshi Yoda
No Relationships to Disclose
 
Leila Dardaei Alghalandis
No Relationships to Disclose
 
Anna F. Farago
Honoraria - Agios; Cell Signaling Technology
 
Jennifer Logan
No Relationships to Disclose
 
Katherine Schultz
No Relationships to Disclose
 
Lecia V. Sequist
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Merrimack; Novartis; Taiho Pharmaceutical
Research Funding - ArQule (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Genentech (Inst); Johnson & Johnson (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Jeffrey A. Engelman
Stock and Other Ownership Interests - Agios; Loxo
Consulting or Advisory Role - Amgen; Asana Biosciences; AstraZeneca; AVEO; Cell Signaling Technology; Chugai Pharma; Clovis Oncology; EMD Serono; GlaxoSmithKline; Merck; Novartis; Roche/Genentech; Sanofi; Synta; Ventana Medical Systems
Research Funding - Amgen; AstraZeneca; GlaxoSmithKline; Jounce Therapeutics; Novartis; Sanofi; Wellspring
Patents, Royalties, Other Intellectual Property - GATEKEEPER Pharmaceuticals
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech